

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.11563643 |
| 2 | protein localization to kinetochore (GO:0034501) | 5.81557968 |
| 3 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.41738269 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 5.20113663 |
| 5 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.14998200 |
| 6 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.06938877 |
| 7 | rRNA methylation (GO:0031167) | 5.00938705 |
| 8 | rRNA transcription (GO:0009303) | 4.97676663 |
| 9 | negative regulation of telomerase activity (GO:0051974) | 4.96083276 |
| 10 | somite rostral/caudal axis specification (GO:0032525) | 4.92852269 |
| 11 | rRNA modification (GO:0000154) | 4.91106472 |
| 12 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.73977932 |
| 13 | negative regulation of epidermis development (GO:0045683) | 4.69119796 |
| 14 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.67005168 |
| 15 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.66924009 |
| 16 | coenzyme catabolic process (GO:0009109) | 4.63919849 |
| 17 | muscle organ morphogenesis (GO:0048644) | 4.61133089 |
| 18 | quinone metabolic process (GO:1901661) | 4.60588883 |
| 19 | mitotic sister chromatid segregation (GO:0000070) | 4.59963907 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 4.54856386 |
| 21 | proteasome assembly (GO:0043248) | 4.43211337 |
| 22 | cytidine metabolic process (GO:0046087) | 4.42189930 |
| 23 | cytidine catabolic process (GO:0006216) | 4.42189930 |
| 24 | cytidine deamination (GO:0009972) | 4.42189930 |
| 25 | regulation of response to osmotic stress (GO:0047484) | 4.39631849 |
| 26 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.37530152 |
| 27 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.37530152 |
| 28 | cullin deneddylation (GO:0010388) | 4.35845590 |
| 29 | protein localization to chromosome, centromeric region (GO:0071459) | 4.20012292 |
| 30 | regulation of translation in response to stress (GO:0043555) | 4.19734611 |
| 31 | nucleoside transmembrane transport (GO:1901642) | 4.14568061 |
| 32 | histone H4-K12 acetylation (GO:0043983) | 4.13904036 |
| 33 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.09759818 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.07754607 |
| 35 | cellular modified amino acid catabolic process (GO:0042219) | 4.04493202 |
| 36 | histone H4-K5 acetylation (GO:0043981) | 4.01453452 |
| 37 | histone H4-K8 acetylation (GO:0043982) | 4.01453452 |
| 38 | protein deneddylation (GO:0000338) | 4.00351721 |
| 39 | DNA replication checkpoint (GO:0000076) | 3.97237089 |
| 40 | hormone catabolic process (GO:0042447) | 3.97013206 |
| 41 | regulation of mitochondrial translation (GO:0070129) | 3.91916156 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 3.91119922 |
| 43 | formation of translation preinitiation complex (GO:0001731) | 3.87384937 |
| 44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.84550975 |
| 45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.83190096 |
| 46 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.78519805 |
| 47 | maturation of SSU-rRNA (GO:0030490) | 3.76923194 |
| 48 | transcription from mitochondrial promoter (GO:0006390) | 3.76868656 |
| 49 | viral transcription (GO:0019083) | 3.76342498 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 3.74942917 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.74851452 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.74851452 |
| 53 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.73650395 |
| 54 | regulation of cilium movement (GO:0003352) | 3.72923042 |
| 55 | interferon-gamma production (GO:0032609) | 3.72796944 |
| 56 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.72729229 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.72558978 |
| 58 | negative regulation of telomere maintenance (GO:0032205) | 3.71975950 |
| 59 | L-serine metabolic process (GO:0006563) | 3.71797489 |
| 60 | ribosomal large subunit biogenesis (GO:0042273) | 3.70602088 |
| 61 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.70295379 |
| 62 | ribosome assembly (GO:0042255) | 3.69044737 |
| 63 | translational termination (GO:0006415) | 3.67271636 |
| 64 | establishment of integrated proviral latency (GO:0075713) | 3.65580402 |
| 65 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.64361420 |
| 66 | chaperone-mediated protein transport (GO:0072321) | 3.63251413 |
| 67 | notochord development (GO:0030903) | 3.60072755 |
| 68 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.58428154 |
| 69 | heterochromatin organization (GO:0070828) | 3.58275622 |
| 70 | response to dietary excess (GO:0002021) | 3.55973255 |
| 71 | DNA strand elongation (GO:0022616) | 3.55528631 |
| 72 | translational elongation (GO:0006414) | 3.54896776 |
| 73 | sister chromatid segregation (GO:0000819) | 3.54194596 |
| 74 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53083239 |
| 75 | pseudouridine synthesis (GO:0001522) | 3.50726814 |
| 76 | phenol-containing compound catabolic process (GO:0019336) | 3.50185178 |
| 77 | ATP synthesis coupled proton transport (GO:0015986) | 3.47595567 |
| 78 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.47595567 |
| 79 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.46873693 |
| 80 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.43723076 |
| 81 | oxidative phosphorylation (GO:0006119) | 3.43711132 |
| 82 | IMP biosynthetic process (GO:0006188) | 3.43504434 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 3.42844336 |
| 84 | purine nucleobase biosynthetic process (GO:0009113) | 3.42427049 |
| 85 | translational initiation (GO:0006413) | 3.41766708 |
| 86 | * ribonucleoprotein complex biogenesis (GO:0022613) | 3.40813986 |
| 87 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.40376045 |
| 88 | maternal placenta development (GO:0001893) | 3.40190489 |
| 89 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.39837026 |
| 90 | cotranslational protein targeting to membrane (GO:0006613) | 3.39589115 |
| 91 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.39235164 |
| 92 | biotin metabolic process (GO:0006768) | 3.38540049 |
| 93 | tRNA aminoacylation for protein translation (GO:0006418) | 3.38101609 |
| 94 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.37033250 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.37033250 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.37033250 |
| 97 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.36514226 |
| 98 | protein targeting to ER (GO:0045047) | 3.36081399 |
| 99 | protein targeting to mitochondrion (GO:0006626) | 3.35765730 |
| 100 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.35102190 |
| 101 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.35102190 |
| 102 | * translation (GO:0006412) | 3.29750726 |
| 103 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.28982719 |
| 104 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.28982719 |
| 105 | amino acid activation (GO:0043038) | 3.26747714 |
| 106 | tRNA aminoacylation (GO:0043039) | 3.26747714 |
| 107 | mitochondrial DNA replication (GO:0006264) | 3.26096139 |
| 108 | maintenance of protein localization in organelle (GO:0072595) | 3.26083513 |
| 109 | positive regulation of ligase activity (GO:0051351) | 3.25855399 |
| 110 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.25238928 |
| 111 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.24983441 |
| 112 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.22967290 |
| 113 | protein localization to endoplasmic reticulum (GO:0070972) | 3.22077429 |
| 114 | nucleobase biosynthetic process (GO:0046112) | 3.21264158 |
| 115 | primary alcohol catabolic process (GO:0034310) | 3.20816427 |
| 116 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.20615225 |
| 117 | primitive streak formation (GO:0090009) | 3.18706510 |
| 118 | cofactor transport (GO:0051181) | 3.17364337 |
| 119 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.16228465 |
| 120 | * cellular component biogenesis (GO:0044085) | 3.14900236 |
| 121 | histone arginine methylation (GO:0034969) | 3.14705614 |
| 122 | mitochondrial RNA metabolic process (GO:0000959) | 3.11287578 |
| 123 | chromatin assembly (GO:0031497) | 3.10657373 |
| 124 | regulation of telomerase activity (GO:0051972) | 3.10456042 |
| 125 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.10394308 |
| 126 | termination of RNA polymerase III transcription (GO:0006386) | 3.10394308 |
| 127 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.08366616 |
| 128 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.08366616 |
| 129 | establishment of protein localization to mitochondrion (GO:0072655) | 3.07600295 |
| 130 | intestinal epithelial cell development (GO:0060576) | 3.06901505 |
| 131 | regulation of ligase activity (GO:0051340) | 3.05924492 |
| 132 | * ribosome biogenesis (GO:0042254) | 3.05871785 |
| 133 | rRNA processing (GO:0006364) | 3.03574661 |
| 134 | viral life cycle (GO:0019058) | 3.03454181 |
| 135 | spliceosomal snRNP assembly (GO:0000387) | 3.02983532 |
| 136 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.02090768 |
| 137 | mitotic metaphase plate congression (GO:0007080) | 2.99993157 |
| 138 | nucleoside transport (GO:0015858) | 2.99519116 |
| 139 | ribosomal small subunit biogenesis (GO:0042274) | 2.96556978 |
| 140 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.95649061 |
| 141 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.95140437 |
| 142 | branched-chain amino acid catabolic process (GO:0009083) | 2.94998514 |
| 143 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.94956432 |
| 144 | establishment of viral latency (GO:0019043) | 2.94573436 |
| 145 | chromatin remodeling at centromere (GO:0031055) | 2.94558821 |
| 146 | peptidyl-histidine modification (GO:0018202) | 2.94392175 |
| 147 | DNA damage response, detection of DNA damage (GO:0042769) | 2.94391683 |
| 148 | GMP metabolic process (GO:0046037) | 2.93625282 |
| 149 | protein localization to mitochondrion (GO:0070585) | 2.93178259 |
| 150 | valine metabolic process (GO:0006573) | 2.91371690 |
| 151 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.90848444 |
| 152 | IMP metabolic process (GO:0046040) | 2.90625174 |
| 153 | base-excision repair (GO:0006284) | 2.89783710 |
| 154 | cofactor catabolic process (GO:0051187) | 2.89716309 |
| 155 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.89666159 |
| 156 | regulation of gene silencing by miRNA (GO:0060964) | 2.89666159 |
| 157 | regulation of gene silencing by RNA (GO:0060966) | 2.89666159 |
| 158 | regulation of translational fidelity (GO:0006450) | 2.86627384 |
| 159 | rRNA metabolic process (GO:0016072) | 2.86306904 |
| 160 | CENP-A containing nucleosome assembly (GO:0034080) | 2.86191476 |
| 161 | L-ascorbic acid metabolic process (GO:0019852) | 2.85965415 |
| 162 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.85939290 |
| 163 | DNA replication initiation (GO:0006270) | 2.85902777 |
| 164 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85882314 |
| 165 | peptidyl-arginine methylation (GO:0018216) | 2.84771889 |
| 166 | peptidyl-arginine N-methylation (GO:0035246) | 2.84771889 |
| 167 | serine family amino acid biosynthetic process (GO:0009070) | 2.84631819 |
| 168 | mitochondrial DNA metabolic process (GO:0032042) | 2.83854584 |
| 169 | cellular protein complex disassembly (GO:0043624) | 2.79692442 |
| 170 | respiratory electron transport chain (GO:0022904) | 2.79355108 |
| 171 | telomere maintenance via recombination (GO:0000722) | 2.78174367 |
| 172 | retinoic acid receptor signaling pathway (GO:0048384) | 2.77953864 |
| 173 | heme transport (GO:0015886) | 2.76766310 |
| 174 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.72892631 |
| 175 | positive regulation of protein deacetylation (GO:0090312) | 2.72629464 |
| 176 | cardiovascular system development (GO:0072358) | 2.68613006 |
| 177 | regulation of G0 to G1 transition (GO:0070316) | 2.67288650 |
| 178 | apoptotic DNA fragmentation (GO:0006309) | 2.67262596 |
| 179 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.67210551 |
| 180 | nuclear pore complex assembly (GO:0051292) | 2.66438599 |
| 181 | phagocytosis, recognition (GO:0006910) | 2.64842570 |
| 182 | cellular ketone metabolic process (GO:0042180) | 2.64672253 |
| 183 | negative regulation of gene silencing (GO:0060969) | 2.64426281 |
| 184 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.64418703 |
| 185 | histone H4-K16 acetylation (GO:0043984) | 2.62043808 |
| 186 | daunorubicin metabolic process (GO:0044597) | 10.3664435 |
| 187 | polyketide metabolic process (GO:0030638) | 10.3664435 |
| 188 | doxorubicin metabolic process (GO:0044598) | 10.3664435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.61624732 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.54106582 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.54106582 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.54106582 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.30368926 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.30139482 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.36433942 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.79070727 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73725496 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.73482978 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57709042 |
| 12 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.51741691 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.28121939 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.23585815 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.19384031 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.16815340 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.16780309 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.10357129 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06268679 |
| 20 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.04210682 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02938906 |
| 22 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02344149 |
| 23 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.01212171 |
| 24 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.00644613 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.98918091 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.98782818 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95568059 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.95498117 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.95309904 |
| 30 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.90331133 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.84434491 |
| 32 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.84292643 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.83975784 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80625542 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80458309 |
| 36 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.77942625 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74983787 |
| 38 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71554605 |
| 39 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.70053384 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68582414 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.66417071 |
| 42 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65807777 |
| 43 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.63794926 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63043562 |
| 45 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62115107 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59554339 |
| 47 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55033046 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53923255 |
| 49 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.50341098 |
| 50 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49665352 |
| 51 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47898101 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40661719 |
| 53 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.38756887 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38221151 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37846338 |
| 56 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36162927 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35009862 |
| 58 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.32319634 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31903645 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30577955 |
| 61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29823933 |
| 62 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28205055 |
| 63 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.27822436 |
| 64 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.27605805 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.26800812 |
| 66 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.26316314 |
| 67 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26098338 |
| 68 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.26083692 |
| 69 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.24118790 |
| 70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.23236081 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.22085959 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21696409 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19435301 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18459211 |
| 75 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.17375507 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17193848 |
| 77 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.17040030 |
| 78 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16965947 |
| 79 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15106218 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12622118 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12605259 |
| 82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10202681 |
| 83 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10165703 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10032884 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09942809 |
| 86 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.09488983 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08994782 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07964703 |
| 89 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.06835536 |
| 90 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06734005 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06124475 |
| 92 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.05486669 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05009772 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04821655 |
| 95 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.04526335 |
| 96 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04196806 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03764707 |
| 98 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.03519726 |
| 99 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03414693 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01800198 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00021921 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99978347 |
| 103 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99109442 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97270131 |
| 105 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97072565 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96412234 |
| 107 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96310228 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95334356 |
| 109 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95306881 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94635088 |
| 111 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93806532 |
| 112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93248492 |
| 113 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.92807368 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92783776 |
| 115 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91841167 |
| 116 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90003180 |
| 117 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89927765 |
| 118 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89711213 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89692443 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.89520523 |
| 121 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89277902 |
| 122 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.88908433 |
| 123 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85405655 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85387641 |
| 125 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85015412 |
| 126 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84975292 |
| 127 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.83540038 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83290933 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82375805 |
| 130 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82008226 |
| 131 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.81688172 |
| 132 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81439029 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81363241 |
| 134 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81350951 |
| 135 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80050267 |
| 136 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79609551 |
| 137 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79037335 |
| 138 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78829038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 4.25398840 |
| 2 | MP0003011_delayed_dark_adaptation | 4.15590838 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.64613117 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.43319878 |
| 5 | MP0002254_reproductive_system_inflammat | 3.18188364 |
| 6 | MP0006035_abnormal_mitochondrial_morpho | 3.07768701 |
| 7 | MP0005075_abnormal_melanosome_morpholog | 2.96481696 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 2.93648288 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.82877481 |
| 10 | MP0008057_abnormal_DNA_replication | 2.82363023 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.80372506 |
| 12 | MP0005394_taste/olfaction_phenotype | 2.53204496 |
| 13 | MP0005499_abnormal_olfactory_system | 2.53204496 |
| 14 | MP0004858_abnormal_nervous_system | 2.34903568 |
| 15 | MP0003122_maternal_imprinting | 2.31579658 |
| 16 | MP0003718_maternal_effect | 2.20988041 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.20145659 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.11422482 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.03132937 |
| 20 | MP0003186_abnormal_redox_activity | 1.97227063 |
| 21 | MP0003567_abnormal_fetal_cardiomyocyte | 1.94950032 |
| 22 | MP0005266_abnormal_metabolism | 1.94741998 |
| 23 | MP0003136_yellow_coat_color | 1.90279868 |
| 24 | MP0001661_extended_life_span | 1.84187889 |
| 25 | MP0004233_abnormal_muscle_weight | 1.82685399 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.82432473 |
| 27 | MP0003077_abnormal_cell_cycle | 1.82347822 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.81239093 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.81029101 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.80907842 |
| 31 | MP0001672_abnormal_embryogenesis/_devel | 1.78443251 |
| 32 | MP0005380_embryogenesis_phenotype | 1.78443251 |
| 33 | MP0003123_paternal_imprinting | 1.77399012 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.75306652 |
| 35 | MP0001529_abnormal_vocalization | 1.74350700 |
| 36 | MP0008995_early_reproductive_senescence | 1.68469133 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.68131728 |
| 38 | MP0009697_abnormal_copulation | 1.67067974 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.66233855 |
| 40 | MP0002088_abnormal_embryonic_growth/wei | 1.64580095 |
| 41 | MP0003984_embryonic_growth_retardation | 1.64000260 |
| 42 | MP0009672_abnormal_birth_weight | 1.61895297 |
| 43 | MP0002938_white_spotting | 1.61767313 |
| 44 | MP0003121_genomic_imprinting | 1.59261586 |
| 45 | MP0004043_abnormal_pH_regulation | 1.57254338 |
| 46 | MP0002127_abnormal_cardiovascular_syste | 1.55470814 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.53191660 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.43466606 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.43100480 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.42705937 |
| 51 | MP0002210_abnormal_sex_determination | 1.42704776 |
| 52 | MP0006082_CNS_inflammation | 1.41114346 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.39570601 |
| 54 | MP0002163_abnormal_gland_morphology | 1.37581675 |
| 55 | MP0005365_abnormal_bile_salt | 1.32750273 |
| 56 | MP0002132_abnormal_respiratory_system | 1.30258477 |
| 57 | MP0000358_abnormal_cell_content/ | 1.28353165 |
| 58 | MP0010094_abnormal_chromosome_stability | 1.28005759 |
| 59 | MP0003646_muscle_fatigue | 1.26142280 |
| 60 | MP0002970_abnormal_white_adipose | 1.25876769 |
| 61 | MP0001293_anophthalmia | 1.23184241 |
| 62 | MP0002269_muscular_atrophy | 1.21598419 |
| 63 | MP0001145_abnormal_male_reproductive | 1.20227139 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.19949311 |
| 65 | MP0000749_muscle_degeneration | 1.19700428 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19435660 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.18815386 |
| 68 | MP0005360_urolithiasis | 1.17860745 |
| 69 | MP0001929_abnormal_gametogenesis | 1.17603887 |
| 70 | MP0000490_abnormal_crypts_of | 1.17090570 |
| 71 | MP0001764_abnormal_homeostasis | 1.15950804 |
| 72 | MP0003942_abnormal_urinary_system | 1.15610421 |
| 73 | MP0003941_abnormal_skin_development | 1.13854141 |
| 74 | MP0001849_ear_inflammation | 1.13158859 |
| 75 | MP0008932_abnormal_embryonic_tissue | 1.11025781 |
| 76 | MP0001730_embryonic_growth_arrest | 1.10246140 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 1.08808381 |
| 78 | MP0000653_abnormal_sex_gland | 1.08282293 |
| 79 | MP0000313_abnormal_cell_death | 1.08149130 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.08096430 |
| 81 | MP0003878_abnormal_ear_physiology | 1.07709343 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 1.07709343 |
| 83 | MP0002085_abnormal_embryonic_tissue | 1.07340998 |
| 84 | MP0000750_abnormal_muscle_regeneration | 1.06686192 |
| 85 | MP0008007_abnormal_cellular_replicative | 1.04382373 |
| 86 | MP0002932_abnormal_joint_morphology | 1.03241448 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.01963916 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 1.00197229 |
| 89 | MP0004133_heterotaxia | 1.00126663 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.97670745 |
| 91 | MP0002092_abnormal_eye_morphology | 0.97533366 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.96999396 |
| 93 | MP0000516_abnormal_urinary_system | 0.96999396 |
| 94 | MP0000609_abnormal_liver_physiology | 0.96647089 |
| 95 | MP0002080_prenatal_lethality | 0.96251441 |
| 96 | MP0002160_abnormal_reproductive_system | 0.95979280 |
| 97 | MP0001697_abnormal_embryo_size | 0.95322691 |
| 98 | MP0002697_abnormal_eye_size | 0.94381755 |
| 99 | MP0004147_increased_porphyrin_level | 0.94286672 |
| 100 | MP0003698_abnormal_male_reproductive | 0.92114547 |
| 101 | MP0001286_abnormal_eye_development | 0.90914656 |
| 102 | MP0008260_abnormal_autophagy | 0.89428161 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.89312586 |
| 104 | MP0005670_abnormal_white_adipose | 0.89169902 |
| 105 | MP0003938_abnormal_ear_development | 0.87987715 |
| 106 | MP0002102_abnormal_ear_morphology | 0.87855297 |
| 107 | MP0005379_endocrine/exocrine_gland_phen | 0.86704096 |
| 108 | MP0002084_abnormal_developmental_patter | 0.85133077 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.84433622 |
| 110 | MP0008789_abnormal_olfactory_epithelium | 0.83961824 |
| 111 | MP0004197_abnormal_fetal_growth/weight/ | 0.81710083 |
| 112 | MP0005332_abnormal_amino_acid | 0.81447383 |
| 113 | MP0003119_abnormal_digestive_system | 0.80841741 |
| 114 | MP0000858_altered_metastatic_potential | 0.80459254 |
| 115 | MP0005023_abnormal_wound_healing | 0.79992367 |
| 116 | MP0001119_abnormal_female_reproductive | 0.79278389 |
| 117 | MP0002161_abnormal_fertility/fecundity | 0.79040620 |
| 118 | MP0000598_abnormal_liver_morphology | 0.78783728 |
| 119 | MP0005501_abnormal_skin_physiology | 0.78213075 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.77699647 |
| 121 | MP0000343_altered_response_to | 0.77289313 |
| 122 | MP0000049_abnormal_middle_ear | 0.77213310 |
| 123 | MP0003315_abnormal_perineum_morphology | 0.76674508 |
| 124 | MP0000762_abnormal_tongue_morphology | 0.76189186 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.74632798 |
| 126 | MP0005410_abnormal_fertilization | 0.74482250 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.73962109 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.72933913 |
| 129 | MP0001348_abnormal_lacrimal_gland | 0.72130593 |
| 130 | MP0002111_abnormal_tail_morphology | 0.71502527 |
| 131 | MP0008770_decreased_survivor_rate | 0.70821264 |
| 132 | MP0003786_premature_aging | 0.70492636 |
| 133 | MP0009703_decreased_birth_body | 0.69196204 |
| 134 | MP0004381_abnormal_hair_follicle | 0.68983108 |
| 135 | MP0003283_abnormal_digestive_organ | 0.68443583 |
| 136 | MP0005330_cardiomyopathy | 0.68086885 |
| 137 | MP0002233_abnormal_nose_morphology | 0.68052580 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.65366656 |
| 139 | MP0009840_abnormal_foam_cell | 0.64718254 |
| 140 | MP0002114_abnormal_axial_skeleton | 0.64709679 |
| 141 | MP0002736_abnormal_nociception_after | 0.64651124 |
| 142 | MP0005384_cellular_phenotype | 0.64022360 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.63987861 |
| 144 | MP0008058_abnormal_DNA_repair | 0.63423218 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.61872689 |
| 146 | MP0002638_abnormal_pupillary_reflex | 0.61273149 |
| 147 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61012827 |
| 148 | MP0003699_abnormal_female_reproductive | 0.60221043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.21941007 |
| 2 | Multiple enchondromatosis (HP:0005701) | 6.11823728 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 5.72396856 |
| 4 | Hepatoblastoma (HP:0002884) | 4.56179036 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.50379225 |
| 6 | Reticulocytopenia (HP:0001896) | 4.38775417 |
| 7 | Ragged-red muscle fibers (HP:0003200) | 4.08304892 |
| 8 | Ependymoma (HP:0002888) | 4.04363921 |
| 9 | Rib fusion (HP:0000902) | 3.93792870 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.90403822 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84309417 |
| 12 | Testicular atrophy (HP:0000029) | 3.77612042 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.76298928 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.63284100 |
| 15 | Abnormal cartilage morphology (HP:0002763) | 3.58889068 |
| 16 | Acute encephalopathy (HP:0006846) | 3.55107218 |
| 17 | Increased CSF lactate (HP:0002490) | 3.39035992 |
| 18 | Rhabdomyosarcoma (HP:0002859) | 3.38488005 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.37618783 |
| 20 | Mitochondrial inheritance (HP:0001427) | 3.36849508 |
| 21 | Increased hepatocellular lipid droplets (HP:0006565) | 3.35705857 |
| 22 | Neoplasm of striated muscle (HP:0009728) | 3.22108936 |
| 23 | Trismus (HP:0000211) | 3.21868323 |
| 24 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.20896629 |
| 25 | Hypoplasia of the fovea (HP:0007750) | 3.20896629 |
| 26 | Hepatocellular necrosis (HP:0001404) | 3.20367191 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 3.17794411 |
| 28 | Progressive muscle weakness (HP:0003323) | 3.15249214 |
| 29 | Increased intramyocellular lipid droplets (HP:0012240) | 3.14736681 |
| 30 | Chromsome breakage (HP:0040012) | 3.10305381 |
| 31 | Hyperglycinemia (HP:0002154) | 3.09187417 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.07572820 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 3.05553444 |
| 34 | Increased serum lactate (HP:0002151) | 3.02950991 |
| 35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00895309 |
| 36 | Macrocytic anemia (HP:0001972) | 3.00826281 |
| 37 | Hepatic necrosis (HP:0002605) | 2.99247376 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98578771 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98578771 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.96488503 |
| 41 | Hyperglycinuria (HP:0003108) | 2.94947526 |
| 42 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.91141441 |
| 43 | Abnormal gallbladder physiology (HP:0012438) | 2.89042177 |
| 44 | Cholecystitis (HP:0001082) | 2.89042177 |
| 45 | Rectal fistula (HP:0100590) | 2.88972154 |
| 46 | Rectovaginal fistula (HP:0000143) | 2.88972154 |
| 47 | Abnormality of glycolysis (HP:0004366) | 2.83454768 |
| 48 | Increased serum pyruvate (HP:0003542) | 2.83454768 |
| 49 | Amyotrophic lateral sclerosis (HP:0007354) | 2.83389127 |
| 50 | Lactic acidosis (HP:0003128) | 2.82942944 |
| 51 | Abnormal number of erythroid precursors (HP:0012131) | 2.82664449 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.80152635 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80027623 |
| 54 | Progressive macrocephaly (HP:0004481) | 2.75935690 |
| 55 | Fused cervical vertebrae (HP:0002949) | 2.75191688 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.74856844 |
| 57 | Vaginal fistula (HP:0004320) | 2.71469437 |
| 58 | Increased muscle lipid content (HP:0009058) | 2.71312318 |
| 59 | Abnormality of the salivary glands (HP:0010286) | 2.67565802 |
| 60 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.66681312 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.66084432 |
| 62 | Embryonal renal neoplasm (HP:0011794) | 2.65616936 |
| 63 | Exercise intolerance (HP:0003546) | 2.62246209 |
| 64 | Cerebral edema (HP:0002181) | 2.61844964 |
| 65 | Progressive external ophthalmoplegia (HP:0000590) | 2.57745317 |
| 66 | Abnormal lung lobation (HP:0002101) | 2.57634509 |
| 67 | Hypochromic anemia (HP:0001931) | 2.55361536 |
| 68 | Respiratory difficulties (HP:0002880) | 2.49213703 |
| 69 | Anomalous pulmonary venous return (HP:0010772) | 2.48865555 |
| 70 | Abnormality of the astrocytes (HP:0100707) | 2.48574413 |
| 71 | Astrocytoma (HP:0009592) | 2.48574413 |
| 72 | Short humerus (HP:0005792) | 2.48360625 |
| 73 | Methylmalonic aciduria (HP:0012120) | 2.48200609 |
| 74 | Abnormality of homocysteine metabolism (HP:0010919) | 2.46283372 |
| 75 | Homocystinuria (HP:0002156) | 2.46283372 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46183391 |
| 77 | Partial duplication of thumb phalanx (HP:0009944) | 2.43334439 |
| 78 | Abnormality of the labia minora (HP:0012880) | 2.42792986 |
| 79 | Tongue fasciculations (HP:0001308) | 2.42542892 |
| 80 | Abnormality of the fovea (HP:0000493) | 2.41135052 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 2.40794130 |
| 82 | CNS hypomyelination (HP:0003429) | 2.40466603 |
| 83 | Intestinal fistula (HP:0100819) | 2.39023186 |
| 84 | Hyperventilation (HP:0002883) | 2.38034519 |
| 85 | Meckel diverticulum (HP:0002245) | 2.36417162 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.34862080 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.34862080 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.34862080 |
| 89 | Abnormal glycosylation (HP:0012345) | 2.34862080 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.33155248 |
| 91 | Microretrognathia (HP:0000308) | 2.32719102 |
| 92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.29813804 |
| 93 | Birth length less than 3rd percentile (HP:0003561) | 2.29272938 |
| 94 | Horseshoe kidney (HP:0000085) | 2.27609394 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26275497 |
| 96 | Abnormality of alanine metabolism (HP:0010916) | 2.26275497 |
| 97 | Hyperalaninemia (HP:0003348) | 2.26275497 |
| 98 | Muscle fibrillation (HP:0010546) | 2.25852115 |
| 99 | Combined immunodeficiency (HP:0005387) | 2.25382231 |
| 100 | Malnutrition (HP:0004395) | 2.25364350 |
| 101 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.25125643 |
| 102 | Gout (HP:0001997) | 2.24693648 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24502350 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24502350 |
| 105 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24502350 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 2.24001935 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.24001935 |
| 108 | Horizontal nystagmus (HP:0000666) | 2.23793601 |
| 109 | Bifid tongue (HP:0010297) | 2.22807600 |
| 110 | Premature ovarian failure (HP:0008209) | 2.22490436 |
| 111 | Spastic paraparesis (HP:0002313) | 2.20621472 |
| 112 | Abnormality of the ileum (HP:0001549) | 2.19720389 |
| 113 | Colon cancer (HP:0003003) | 2.16682628 |
| 114 | Angiofibromas (HP:0010615) | 2.15466315 |
| 115 | Adenoma sebaceum (HP:0009720) | 2.15466315 |
| 116 | Lethargy (HP:0001254) | 2.15433548 |
| 117 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.14654970 |
| 118 | Cheilitis (HP:0100825) | 2.13621129 |
| 119 | Short 5th finger (HP:0009237) | 2.12460178 |
| 120 | Skin nodule (HP:0200036) | 2.11167346 |
| 121 | Absent thumb (HP:0009777) | 2.10460418 |
| 122 | Abnormality of the preputium (HP:0100587) | 2.09487613 |
| 123 | Increased connective tissue (HP:0009025) | 2.07358810 |
| 124 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07279765 |
| 125 | Partial duplication of the phalanx of hand (HP:0009999) | 2.06981455 |
| 126 | Impulsivity (HP:0100710) | 2.06558512 |
| 127 | Postnatal microcephaly (HP:0005484) | 2.05929372 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 2.04469520 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04469520 |
| 130 | Abnormality of reticulocytes (HP:0004312) | 2.04011005 |
| 131 | Fasciculations (HP:0002380) | 2.02912405 |
| 132 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02192016 |
| 133 | Abnormality of the pulmonary veins (HP:0011718) | 2.01642607 |
| 134 | Abnormality of the anterior horn cell (HP:0006802) | 2.01171090 |
| 135 | Degeneration of anterior horn cells (HP:0002398) | 2.01171090 |
| 136 | Pallor (HP:0000980) | 2.00881515 |
| 137 | Hypoplastic pelvis (HP:0008839) | 2.00072241 |
| 138 | Abnormality of DNA repair (HP:0003254) | 1.99308864 |
| 139 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.98486210 |
| 140 | Respiratory failure (HP:0002878) | 1.98414976 |
| 141 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.98129755 |
| 142 | Tetraplegia (HP:0002445) | 1.98081736 |
| 143 | Poor suck (HP:0002033) | 1.97594541 |
| 144 | Triphalangeal thumb (HP:0001199) | 1.96815053 |
| 145 | Preauricular skin tag (HP:0000384) | 1.95425851 |
| 146 | Pendular nystagmus (HP:0012043) | 1.95266075 |
| 147 | Shawl scrotum (HP:0000049) | 1.94936363 |
| 148 | Aplastic anemia (HP:0001915) | 1.94313259 |
| 149 | Abnormal neuron morphology (HP:0012757) | 1.93596140 |
| 150 | Abnormality of the motor neurons (HP:0002450) | 1.93596140 |
| 151 | Poor head control (HP:0002421) | 1.93509992 |
| 152 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93358065 |
| 153 | Poikiloderma (HP:0001029) | 1.90554043 |
| 154 | Leukodystrophy (HP:0002415) | 1.90363932 |
| 155 | Methylmalonic acidemia (HP:0002912) | 1.89262842 |
| 156 | Villous atrophy (HP:0011473) | 1.88460130 |
| 157 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.88460130 |
| 158 | Secondary amenorrhea (HP:0000869) | 1.87553527 |
| 159 | Emotional lability (HP:0000712) | 1.86299141 |
| 160 | Megaloblastic anemia (HP:0001889) | 1.86220306 |
| 161 | Sparse eyelashes (HP:0000653) | 1.85505188 |
| 162 | Entropion (HP:0000621) | 1.85145775 |
| 163 | Hand muscle atrophy (HP:0009130) | 1.84936174 |
| 164 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.84911287 |
| 165 | Pancytopenia (HP:0001876) | 1.84871059 |
| 166 | Limb hypertonia (HP:0002509) | 1.83152534 |
| 167 | Periauricular skin pits (HP:0100277) | 1.82961293 |
| 168 | Preauricular pit (HP:0004467) | 1.82961293 |
| 169 | Abnormal hemoglobin (HP:0011902) | 1.82634385 |
| 170 | Hyperammonemia (HP:0001987) | 1.80964013 |
| 171 | Opisthotonus (HP:0002179) | 1.76764811 |
| 172 | Optic disc pallor (HP:0000543) | 1.75878062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.03392920 |
| 2 | ERN1 | 5.33869855 |
| 3 | GRK5 | 4.53202671 |
| 4 | VRK2 | 4.26749778 |
| 5 | GRK6 | 4.15630564 |
| 6 | TTK | 2.98338510 |
| 7 | ADRBK2 | 2.97420166 |
| 8 | GRK1 | 2.73358767 |
| 9 | CSF1R | 2.57943250 |
| 10 | TSSK6 | 2.43911897 |
| 11 | PBK | 2.42999413 |
| 12 | STK10 | 2.28888439 |
| 13 | GRK7 | 2.27649837 |
| 14 | ZAK | 2.20477201 |
| 15 | MAPK7 | 2.14240645 |
| 16 | NME1 | 2.13322782 |
| 17 | TGFBR2 | 2.11786780 |
| 18 | BUB1 | 2.03614413 |
| 19 | BCKDK | 1.99256841 |
| 20 | EPHA2 | 1.97314237 |
| 21 | MATK | 1.96735930 |
| 22 | MOS | 1.89974741 |
| 23 | PLK3 | 1.86382784 |
| 24 | TYRO3 | 1.72509307 |
| 25 | TRIM28 | 1.69288628 |
| 26 | CDK7 | 1.65822891 |
| 27 | PLK4 | 1.54852050 |
| 28 | NUAK1 | 1.48319665 |
| 29 | PAK4 | 1.45691314 |
| 30 | NEK1 | 1.40578691 |
| 31 | PRKG2 | 1.40125350 |
| 32 | CDK19 | 1.37985955 |
| 33 | PLK1 | 1.37103034 |
| 34 | WEE1 | 1.31763049 |
| 35 | CHEK2 | 1.22119733 |
| 36 | WNK1 | 1.21571101 |
| 37 | TAF1 | 1.21191065 |
| 38 | MST4 | 1.21160291 |
| 39 | TESK2 | 1.20540093 |
| 40 | NME2 | 1.20056020 |
| 41 | AKT3 | 1.18564728 |
| 42 | SMG1 | 1.15630928 |
| 43 | CAMK4 | 1.14930404 |
| 44 | NTRK1 | 1.03726923 |
| 45 | MAP2K6 | 0.98634216 |
| 46 | ADRBK1 | 0.94296716 |
| 47 | MAP4K2 | 0.93216032 |
| 48 | DAPK1 | 0.89816723 |
| 49 | LATS2 | 0.87513230 |
| 50 | TAOK2 | 0.86813194 |
| 51 | MKNK1 | 0.84313724 |
| 52 | PIM2 | 0.83861289 |
| 53 | NEK2 | 0.82891442 |
| 54 | CSNK1G3 | 0.82283751 |
| 55 | LIMK1 | 0.81959012 |
| 56 | TLK1 | 0.80161183 |
| 57 | RPS6KB2 | 0.79776450 |
| 58 | HIPK2 | 0.77177807 |
| 59 | PRKCI | 0.76125246 |
| 60 | CDC7 | 0.74968452 |
| 61 | MAP3K10 | 0.72787380 |
| 62 | AURKA | 0.72690556 |
| 63 | MAP2K4 | 0.72535958 |
| 64 | AKT2 | 0.69860611 |
| 65 | MARK2 | 0.69579414 |
| 66 | MAPKAPK3 | 0.69380204 |
| 67 | RPS6KA4 | 0.68239018 |
| 68 | CSNK2A2 | 0.68173816 |
| 69 | CHEK1 | 0.67801772 |
| 70 | CSNK2A1 | 0.66851398 |
| 71 | FLT3 | 0.63684039 |
| 72 | AURKB | 0.62366746 |
| 73 | EIF2AK2 | 0.62010529 |
| 74 | ALK | 0.61853432 |
| 75 | WNK3 | 0.61669134 |
| 76 | CSNK1G1 | 0.61384873 |
| 77 | EIF2AK1 | 0.60743439 |
| 78 | CDK8 | 0.60074223 |
| 79 | LRRK2 | 0.59067773 |
| 80 | CSK | 0.58856938 |
| 81 | PRKD3 | 0.57520066 |
| 82 | KDR | 0.56051375 |
| 83 | EEF2K | 0.53667934 |
| 84 | WNK4 | 0.52984704 |
| 85 | MAP3K8 | 0.52625515 |
| 86 | SIK1 | 0.52044287 |
| 87 | MAPK12 | 0.51725750 |
| 88 | BRSK2 | 0.51677420 |
| 89 | BRAF | 0.51385642 |
| 90 | ARAF | 0.49873914 |
| 91 | STK16 | 0.48480438 |
| 92 | CDK1 | 0.47682447 |
| 93 | PAK1 | 0.46716319 |
| 94 | ILK | 0.45359120 |
| 95 | CSNK1A1L | 0.44941690 |
| 96 | PDK2 | 0.44054412 |
| 97 | CSNK1G2 | 0.43239943 |
| 98 | PRKCD | 0.42694325 |
| 99 | PDK4 | 0.42637787 |
| 100 | PDK3 | 0.42637787 |
| 101 | RPS6KA5 | 0.42466435 |
| 102 | MAPKAPK5 | 0.41855515 |
| 103 | SRPK1 | 0.41468653 |
| 104 | MAP3K7 | 0.41223870 |
| 105 | BCR | 0.40793004 |
| 106 | FGFR3 | 0.40784771 |
| 107 | CDK4 | 0.40128202 |
| 108 | CCNB1 | 0.39398063 |
| 109 | CDK2 | 0.39199783 |
| 110 | CLK1 | 0.38662290 |
| 111 | ACVR1B | 0.37819556 |
| 112 | DYRK3 | 0.37052630 |
| 113 | BMX | 0.35781749 |
| 114 | SIK3 | 0.33616699 |
| 115 | MTOR | 0.33519121 |
| 116 | SCYL2 | 0.33484054 |
| 117 | DAPK3 | 0.33031912 |
| 118 | LMTK2 | 0.31960907 |
| 119 | DYRK2 | 0.31905463 |
| 120 | BRSK1 | 0.31878214 |
| 121 | CDK14 | 0.31394363 |
| 122 | ABL2 | 0.30816118 |
| 123 | ITK | 0.30209453 |
| 124 | DYRK1B | 0.29739466 |
| 125 | CDK9 | 0.29439344 |
| 126 | IRAK3 | 0.29198999 |
| 127 | CDK11A | 0.28143666 |
| 128 | MAP3K5 | 0.28001123 |
| 129 | MAPK4 | 0.27769933 |
| 130 | PTK2 | 0.27176575 |
| 131 | IGF1R | 0.26783805 |
| 132 | BLK | 0.26778464 |
| 133 | PRKDC | 0.25788623 |
| 134 | PKN2 | 0.25384310 |
| 135 | STK38L | 0.24936040 |
| 136 | IKBKB | 0.24902281 |
| 137 | TESK1 | 0.24741638 |
| 138 | ATM | 0.24581942 |
| 139 | CSNK1E | 0.22899838 |
| 140 | EIF2AK3 | 0.22685968 |
| 141 | ATR | 0.22030621 |
| 142 | PRKACG | 0.20692874 |
| 143 | PINK1 | 0.20473861 |
| 144 | PASK | 0.20323006 |
| 145 | PIM1 | 0.18544603 |
| 146 | STK4 | 0.18257908 |
| 147 | TRIB3 | 0.17219535 |
| 148 | VRK1 | 0.17088238 |
| 149 | MAP2K3 | 0.16590800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.90452089 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.61131287 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.35705962 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.25163510 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39122906 |
| 6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.33582951 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.31425924 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29903717 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.29642576 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.08333672 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96675263 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.93932289 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.93637359 |
| 14 | * Ribosome_Homo sapiens_hsa03010 | 1.85933421 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.81506100 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.81187852 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.78002699 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.74675200 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73649295 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.68670814 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62037062 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.61880558 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.59640278 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58637840 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.54600438 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54293343 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53829791 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53039057 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.51541093 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50853170 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45258090 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.40484242 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40417928 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36180812 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.35613449 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35383645 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26414770 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26058818 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23356844 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.22876151 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19994519 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18857908 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18492847 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16931416 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.16498110 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14266354 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06390431 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03949967 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02159752 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 1.00649564 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94108170 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94012666 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.92684920 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92369028 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 0.90380389 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90360790 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90277915 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89358657 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84653051 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.84150653 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82818674 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82497952 |
| 63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79077837 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78766144 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77967375 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75766170 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.74664848 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74368787 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72520630 |
| 70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71125471 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69334086 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67918502 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66998139 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65831544 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65500808 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65107413 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64436257 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64145990 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63274861 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61896295 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59964311 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57114769 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57023443 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55918802 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55230349 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54380298 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54108007 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53016225 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51457065 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50239617 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49377405 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47326601 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46444024 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45280152 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44866214 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44698997 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43818765 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42968404 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41435260 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40709598 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39864926 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38658255 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38602372 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37003637 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36510405 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35618152 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35384107 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33588622 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33204554 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32938023 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.32456016 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31013142 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30666109 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29460937 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28785371 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27927770 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.27148310 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24970358 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.24179777 |
| 120 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18359692 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16887323 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11336598 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10628817 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.09422308 |
| 125 | Tight junction_Homo sapiens_hsa04530 | -0.0353210 |

